Delivery Order SPE2DB22D1106-SPE2DB25FEZA0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lyrica 50 mg capsules (90-count units) at a ceiling value of $1,182.32. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order, with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,851.66 to AmerisourceBergen Drug Corp for the supply of Lyrica 200 mg capsules (90-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $1,810.77 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lyrica 75 mg capsules in unit dose packaging (100 units). This is a firm fixed price contract with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,370.10 to AmerisourceBergen Drug Corp for the supply of Lyrica (pregabalin) 50 mg capsules in a 90-count quantity. This competitive award, issued on July 23, 2025, with a completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,100.28 for Lyrica 300 mg capsules (90-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Lyrica 300 mg capsules (90-count). The contract carries a ceiling value of $1,179.94 under firm fixed pricing terms, with an ultimate completion date of July 25, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a child contract issued under a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,786.46 on July 18, 2025, for the supply of Lyrica 50 mg capsules (90-count units). This contract was awarded on a firm fixed price basis with no set-aside designation, indicating competitive award conditions. The order is scheduled for completion by July 21, 2025, and is being funded through the Medical Supply Chain division of the Department of...
- The Defense Logistics Agency awarded a $1,985.20 delivery order to AmerisourceBergen Drug Corp for 90 units of Lyrica 75 mg capsules, effective July 28, 2025, with completion scheduled for July 29, 2025. This is a firm fixed-price, non-set-aside contract supporting federal pharmaceutical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor to military and veteran healthcare systems and is registered in the System for...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $3,364.43 contract is for the delivery of Lyrica 50 mg capsules, with a performance period through February 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 90 capsules of the pharmaceutical product Lyrica 50 mg. The $1,044.74 delivery order has a completion date of December 20, 2023 and was awarded on December 19, 2023. Amerisourcebergen Drug Corp, which operates out of its corporate office in Conshohocken, Pennsylvania, has previously received numerous federal contract awards from...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZA0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lyrica 50 mg capsules (90-count units) valued at $6,567.28. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified vendor. The order is to be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical supply vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to federal healthcare systems, particularly the Defense Health Agency and military medical supply chains. As a leading vendor in the pharmaceutical distribution sector, the company maintains extensive federal contract portfolios encompassing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The DLA Troop Support Medical relationship demonstrates the vendor's capability to meet substantial federal pharmaceutical supply requirements on a global scale, supporting military healthcare operations and related government health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 7/22/25 |